Why did shortage-era compounded pricing end?
It ended because the shortage that allowed it ended. While semaglutide was on the FDA’s drug shortage list, compounding pharmacies could legally make copies of it at scale, which is what supported low monthly prices. Once supply recovered, that permission ran out.
| Date | What changed |
|---|---|
| December 19, 2024 | The FDA determined the tirzepatide shortage was resolved |
| February 21, 2025 | The FDA determined the semaglutide shortage was resolved |
| April 2025 | The grace period ended for 503A pharmacies making copies of semaglutide |
| May 22, 2025 | The grace period ended for 503B outsourcing facilities |
| April 1, 2026 | The FDA reminded compounders of the conditions they must meet |
The FDA’s policy page for compounders records each of those steps. For the legal background in plain terms, see is compounded semaglutide legal in 2026.
When is 503A compounding still allowed?
A state-licensed 503A pharmacy can still compound semaglutide for one identified patient, on that patient’s individual order, under narrow conditions. The key test is whether the product is “essentially a copy” of an approved drug: same active ingredient, a similar or easily substituted strength, and the same route.
A copy is acceptable only when the clinician determines and documents that the compounded version contains a change that makes a significant difference for that specific patient. The FDA has also said it does not currently intend to act against a pharmacy that fills four or fewer orders of a copy in a calendar month. Two more limits matter:
- Added ingredients do not create an exemption on their own. The FDA’s example is semaglutide combined with vitamin B12, which may still count as a copy.
- Salt forms are out. The FDA’s page on unapproved GLP-1 drugs states that semaglutide sodium and semaglutide acetate should not be used to compound semaglutide.
Our explainer on 503A versus 503B compounding pharmacies covers the difference between the two pharmacy types.
What does that mean for the price?
Individualized compounding is a low-volume medical exception, and that changes its cost. These are the pieces that drive it:
| Cost driver | Why it matters now |
|---|---|
| The documented clinical reason | A clinician has to evaluate you and record why the approved product does not meet your need |
| Individual preparation | A 503A pharmacy makes it for you alone rather than in large batches |
| Quality and dosing support | Compounded drugs are not FDA-approved, and the FDA has reported dosing errors with compounded injectable semaglutide |
| Ongoing monitoring | The same labs, scans and check-ins as any supervised program |
Meanwhile, the brand price has dropped. As of October 8, 2026, NovoCare lists Wegovy pens at $349 a month for standard doses. That narrows the gap that once made compounding attractive. Our comparison of compounded semaglutide and Wegovy sets the two side by side, and semaglutide cost without insurance breaks down the brand price by dose.
Questions to ask about any compounded GLP-1
Ask these before you pay for any compounded semaglutide, from any source:
- What is the documented clinical reason the approved product will not work for me?
- Which licensed pharmacy makes it, and is it a 503A pharmacy?
- Is the active ingredient semaglutide base, not a salt form?
- How is my dose measured, and who shows me how to draw it up?
- What labs and follow-up come with it?
The FDA’s compounding questions and answers is a useful plain-language background read, and our post on research-use semaglutide warnings explains why products sold “for research” are a different and riskier category.
FSA, HSA and payment
Pre-tax funds can apply to compounded or brand semaglutide used to treat diagnosed obesity. IRS Publication 502 counts medicines that need a clinician’s order and weight loss treatment for a disease a physician has diagnosed, and your plan administrator decides each claim. Ultimate Male is direct-pay, gives itemized receipts for FSA, HSA and out-of-network claims, and offers financing through CareCredit, Prosper Healthcare Lending and Afterpay.
How Ultimate Male approaches compounded semaglutide
Your provider starts with whether an FDA-approved product fits your health and goals. Compounded semaglutide comes into the conversation only when there is a documented clinical reason, and it is sourced from licensed U.S. compounding pharmacies. No one at the clinic will promise a compounded option before your evaluation.
Begin with the free 10-minute call, then labs and a one-on-one consultation with a PA-C or MD. You get a quote before booking, whichever medicine your provider recommends, and the medical weight loss program covers the evaluation, labs, body composition analysis and check-ins that come with it.
